Uni-Bio Science Group (HKSE:00690) Debt-to-Equity : 0.22 (As of Dec. 2023)

View and export this data going back to 2001. Start your Free Trial

What is Uni-Bio Science Group Debt-to-Equity?

Uni-Bio Science Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$18.7 Mil. Uni-Bio Science Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$37.6 Mil. Uni-Bio Science Group's Total Stockholders Equity for the quarter that ended in Dec. 2023 was HK$257.2 Mil. Uni-Bio Science Group's debt to equity for the quarter that ended in Dec. 2023 was 0.22.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Uni-Bio Science Group's Debt-to-Equity or its related term are showing as below:

HKSE:00690' s Debt-to-Equity Range Over the Past 10 Years
Min: 0.01 Med: 0.03 Max: 0.22
Current: 0.22

During the past 13 years, the highest Debt-to-Equity Ratio of Uni-Bio Science Group was 0.22. The lowest was 0.01. And the median was 0.03.

HKSE:00690's Debt-to-Equity is ranked worse than
57.83% of 1060 companies
in the Biotechnology industry
Industry Median: 0.14 vs HKSE:00690: 0.22

Uni-Bio Science Group Debt-to-Equity Historical Data

The historical data trend for Uni-Bio Science Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Uni-Bio Science Group Debt-to-Equity Chart

Uni-Bio Science Group Annual Data

Trend

Mar14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Equity

Get a 7-Day Free Trial

0.01

0.02

0.03

0.12

0.22

Uni-Bio Science Group Semi-Annual Data
	Mar14	Sep14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Equity	Get a 7-Day Free Trial															0.03	0.05	0.12	0.09	0.22

Competitive Comparison of Uni-Bio Science Group's Debt-to-Equity

For the Biotechnology subindustry, Uni-Bio Science Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Uni-Bio Science Group's Debt-to-Equity Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Uni-Bio Science Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Uni-Bio Science Group's Debt-to-Equity falls into.

Uni-Bio Science Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Uni-Bio Science Group's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.697	+	37.602)	/	257.174
	=	0.22

Uni-Bio Science Group's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(18.697	+	37.602)	/	257.174
	=	0.22

Uni-Bio Science Group (HKSE:00690) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Uni-Bio Science Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Uni-Bio Science Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Uni-Bio Science Group (HKSE:00690) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Uni-Bio Science Group Ltd (HKSE:00690) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 20 Science Park East Avenue, Unit 502, 5th Floor, Hong Kong Science Park, Shatin, New Territories, Hong Kong, HKG

Website

https://www.uni-bioscience.com

Uni-Bio Science Group Ltd is an investment holding company. It operates in three segments: Chemical pharmaceutical products, Biological pharmaceutical products, and Pipeline products. Its geographical segments are Hong Kong and China, of which all of its revenue comes from China. The company products include GeneSoft, GeneTime, Pinup, Boshutai, Bokangtai, and others. All of the company revenue is generated from PRC.

Executives

Automatic Result Limited
Mjkpc Holdings Limited
Leung Kingsley
Century Ally Ventures Limited	2201 Interest of corporation controlled by you
Fih (bvi) Limited	2201 Interest of corporation controlled by you
Petite Arbre Limited	2201 Interest of corporation controlled by you
Tmf (cayman) Ltd.	2301 Trustee
Xjg Capital Management Limited	2201 Interest of corporation controlled by you
Yau Kwok Wing Tony	2201 Interest of corporation controlled by you
Lau Kan Sum	2307 Founder of a discretionary trust who can infl
Credit Suisse Trust Limited	2301 Trustee
Mjkpc Holdings Limited	2201 Interest of corporation controlled by you

Uni-Bio Science Group (HKSE:00690) Headlines

No Headlines